Tal Gavoli

Well, partners and investors that we're in touch with, obviously.

And it never took us six months to raise money, so...

No, more, it's usually bigger, longer deals to longer-term engagement.

So, for example, a clinical trial that wants to be accelerated, it could be a six-figure deal to work with us to help accelerate that trial.

I think it's premature to decide, you know, to determine the deal size per type of deal we have right now.

Yeah, that could be fair, yeah.

Um, I would say that sounds right.

That's how it's going to work.

Okay.

So far, the interesting thing is that the, uh, the last four deals have come to us and closed within three months.

So without us even meeting them.

So yeah, we had phone conversations and so on, but the last deals that actually discovered us online found out that we could help them and engaged with us.

So now we don't think that's going to continue or –

We maximize the market opportunity by doing that.

So we're going to have to have a sales force that actually goes and targets these specific partners for us.

Yeah, so I'm not going to go into that.

But first of all, we didn't launch in 2012.

We launched in 2013.

In the summer of 2013, we had a beta.

The company was launched in 2012.